Newman Ferrara LLP Announces Corporate Governance Investigation of Sorrento Therapeutics, Inc. – SRNE
NEW YORK--(BUSINESS WIRE)--$SRNE #NYTop100--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Sorrento Therapeutics, Inc. (“Sorrento” or the “Company”) (NASDAQ:SRNE) into potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”).
Sorrento, headquartered in…
Read More...
